Levetiracetam
Product Images NDC 50090-2456

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-2456). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

An instruction describing the calculation for total daily dose of Levetiracetam in mL per day, based on daily dose in mg/kg/day multiplied by patient weight in kg, divided by the concentration of 100 mg/mL.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

A pharmacokinetic-related formula panel describing the calculation and adjustment of creatinine clearance (CLcr) using age, weight, serum creatinine, and body surface area (BSA). It includes an adjustment factor for female patients and a formula to normalize CLcr to 1.73 m2 BSA.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure of levetiracetam showing its molecular arrangement including a pyrrolidone ring, ethyl group, and amide functional group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar chart comparing the percentage of patients by treatment group showing placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients from 0% to 45%. The placebo group has 7.4%, Levetiracetam 1000 mg/day group has 37.1%, and Levetiracetam 3000 mg/day group has 39.6%. Sample sizes are also indicated for each group below the x-axis labels.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

A bar graph comparing the percentage of patients across three groups: Placebo (N=111), Levetiracetam 1000 mg/day (N=106), and Levetiracetam 2000 mg/day. The y-axis represents the percentage of patients, with values approximately 6.3% for placebo, 20.8% for 1000 mg/day, and 35.2% for 2000 mg/day.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

A bar chart comparing the percentage of patients in two groups: placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percent of patients, with placebo showing 14.4% and Levetiracetam showing 39.4%, highlighting a difference between the two groups.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The vertical axis shows percentage of patients up to 45%. The placebo group (N=97) has about 19.6%, and the Levetiracetam group (N=101) has about 44.6%. An asterisk marks the bar for Levetiracetam indicating statistical significance or emphasis.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Placebo group shows 19.6%, while the Levetiracetam group shows 43.1%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

A vertical bar chart comparing the percentage of patients by treatment group. The chart displays two bars: one for Placebo with 45.2%, and one for Levetiracetam (N=79) with 72.2%. The y-axis shows patient percentage from 0% to 100%. An asterisk marks the Levetiracetam bar to indicate statistical significance or emphasis.*

FDA Label Image

Label Image (Lbl500902456)

Levetiracetam 500 mg film-coated tablets packaging label from A-S Medication Solutions, LLC. The label includes the product NDC 50090-2456-0, storage instructions to keep at 77 degrees Fahrenheit, and contains 120 tablets per package. It also features dosage and package identifiers with QR codes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.